Related Experiment Videos
Dose dependent pharmacokinetics of prednisolone
European Journal of Clinical Pharmacology
|November 14, 1977
Summary
Prednisolone dosage affects its elimination in the body. Higher doses increase prednisolone half-life and distribution, potentially due to protein binding.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Metabolism
Background:
- Prednisolone is a widely used corticosteroid.
- Understanding its pharmacokinetic profile is crucial for effective therapeutic use.
- Variations in elimination can impact patient outcomes.
Purpose of the Study:
- To investigate the pharmacokinetics of prednisolone elimination.
- To assess the impact of varying doses on pharmacokinetic parameters.
- To explore potential mechanisms behind observed pharmacokinetic changes.
Main Methods:
- Pharmacokinetic study involving healthy volunteers and patients with arthritis.
- Administration of tritiated and unlabelled prednisolone at different doses (0.15 and 0.3 mg/kg).
- Analysis of plasma half-life, volume of distribution, and plasma clearance.
Main Results:
- Increasing prednisolone dose led to a prolonged plasma half-life.
- Higher doses resulted in an increased volume of distribution.
- Plasma clearance of prednisolone also increased with higher doses.
Conclusions:
- Prednisolone pharmacokinetics exhibit dose-dependent changes.
- Non-linear binding to plasma proteins is proposed as a mechanism for these alterations.
- These findings have implications for prednisolone dosing strategies.